Your browser version may not work well with NCBI's Web applications. More information
here...
-
Dipeptides as effective prodrugs of the unnatural amino acid (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740), a selective group II metabotropic glutamate receptor agonist.
Bueno AB,
Collado I,
de Dios A,
Domínguez C,
Martín JA,
Martín LM,
Martínez-Grau MA,
Montero C,
Pedregal C,
Catlow J,
Coffey DS,
Clay MP,
Dantzig AH,
Lindstrom T,
Monn JA,
Jiang H,
Schoepp DD,
Stratford RE,
Tabas LB,
Tizzano JP,
Wright RA,
Herin MF.
Lilly, S.A., Avda. de la Industria 30, 28108 Alcobendas, Madrid, Spain. bueno_ana_belen@lilly.com
(+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (1), also known as LY354740, is a highly potent and selective agonist for group II metabotropic glutamate receptors (mGlu receptors 2 and 3) tested in clinical trials. It has been shown to block anxiety in the fear-potentiated startle model. Its relatively low bioavailability in different animal species drove the need for an effective prodrug form that would produce a therapeutic response at lower doses for the treatment of anxiety disorders. We have investigated the increase of intestinal absorption of this compound by targeting the human peptide transporter hPepT1 for active transport of di- and tripeptides derived from 1. We have found that oral administration of an N dipeptide derivative of 1 (12a) in rats shows up to an 8-fold increase in drug absorption and a 300-fold increase in potency in the fear-potentiated startle model in rats when compared with the parent drug 1.
PMID: 16078848 [PubMed - indexed for MEDLINE]
-
Related Articles
-
Improved bioavailability of the mGlu2/3 receptor agonist LY354740 using a prodrug strategy: in vivo pharmacology of LY544344.
[J Pharmacol Exp Ther. 2006]
-
Pharmacokinetics, metabolism, and excretion of the intestinal peptide transporter 1 (SLC15A1)-targeted prodrug (1S,2S,5R,6S)-2-[(2'S)-(2-amino)propionyl]aminobicyclo[3.1.0.]hexen-2,6-dicarboxylic acid (LY544344) in rats and dogs: assessment of first-pass bioactivation and dose linearity.
[Drug Metab Dispos. 2007]
-
Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors.
[J Pharmacol Exp Ther. 1998]
-
Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
[J Med Chem. 1999]
-
Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonists.
[J Med Chem. 2000]
-
» See all Related Articles...
-
Related Reviews